Key result
Laparoscopic bariatric surgery resulted in a 33.11% total body weight loss and a 93% overall remission rate of type 2 diabetes at 12 months in super-obese Malaysian patients.
Why the study?
Although bariatric surgery benefits super-obese populations, there were no published data on this topic from Malaysia.
Does laparoscopic bariatric surgery improve weight loss and glycemic control in super-obese Malaysian patients with type 2 diabetes mellitus?
Cohort (n=33)
No
Does laparoscopic bariatric surgery improve weight loss and glycemic control in super-obese Malaysian patients with type 2 diabetes mellitus?
Laparoscopic bariatric surgery provides significant weight loss and glycemic control improvement at 12 months in super-obese Malaysian patients with type 2 diabetes.
May support bariatric surgery in super-obese Malaysian T2DM patients; extends limited Asian data but leaves open need for RCTs.
INTRODUCTION: Despite many challenges, the benefit of bariatric surgery in super-obese population remains irrefutable with significant improvement in metabolic syndrome and quality of life. There are currently no published data from Malaysia on this topic. OBJECTIVE AND METHODOLOGY: A single-centre retrospective study aimed at analysing the outcome of laparoscopic bariatric surgery on super-obese Malaysians with type 2 diabetes mellitus (T2DM) at 12 months following surgery. Demographic details, glycaemic control and weight-loss parameters were analysed.P < 0.01 was considered statistically significant. Majority of patients were of Malay ethnicity (82%). Malaysian-Indians and Malaysian-Chinese each accounted for 9% of total case volume. The three types of laparoscopic bariatric surgery recorded in this study were sleeve gastrectomy (82%), Roux-en-Y gastric bypass (9%) and mini-gastric bypass (9%) with operative time of 103.5 ± 31.1, 135.8 ± 32.6 and 116.2 ± 32.3 min, respectively. Percentage total body weight loss was 33.11% ± 9.44% at 12 months following surgery (P < 0.01). BMI change and percentage excess BMI loss showed similar improvement. Glycosylated haemoglobin and fasting blood sugar decreased from pre-operative values of 7.0% ± 1.0% and 7.0 ± 0.9 mmol/L to 5.6% ± 0.4% and 5.0 ± 0.6 mmol/L at 12 months (P < 0.01). Remission of T2DM was noted in 93% of patients. There was no correlation between weight loss and improvement in glycaemic status. CONCLUSION: There are significant weight loss and improvement of glycaemic control at 12 months post-laparoscopic bariatric surgery among super-obese Malaysians.
No takes yet. Share an insight, caveat, or question.
Rajan et al. (2019) conducted a cohort in Type 2 diabetes mellitus and super-obesity (n=33). Laparoscopic bariatric surgery vs. Pre-operative baseline was evaluated on Percentage total body weight loss (%TBWL) at 12 months (p=<0.01). Laparoscopic bariatric surgery resulted in a 33.11% total body weight loss and a 93% overall remission rate of type 2 diabetes at 12 months in super-obese Malaysian patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: